LUD00-014: Phase I Study of recombinant vaccinia-NY-ESO-1 (rV-NY-ESO-1) and recombinant fowlpox-NY-ESO-1 (rF-NY-ESO-1) in patients with NY-ESO-1 or LAGE positive cancersArmin Bender, Elke Jäger, Antje Neumann et al.|Cancer Cell International|2004Cited by 2